Nasdaq Prph News Today

HC Wainwright reiterated their buy rating on shares of ProPhase Labs (NASDAQ:PRPH – Free Report) in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. ProPhase Labs Price Performance PRPH stock opened at $4.96 on Wednesday. The company has a fifty day moving average […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $5.44 and traded as low as $4.56. ProPhase Labs shares last traded at $4.73, with a volume of 29,277 shares. Wall Street Analyst […]

ProPhase Labs (NASDAQ:PRPH – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Thursday, November 9th. Analysts expect ProPhase Labs to post earnings of ($0.20) per share for the quarter. ProPhase Labs (NASDAQ:PRPH – Get Free Report) last issued its quarterly earnings results on Thursday, August 10th. The […]

StockNews.com upgraded shares of ProPhase Labs (NASDAQ:PRPH – Free Report) from a sell rating to a hold rating in a research note released on Wednesday. Separately, HC Wainwright reiterated a buy rating and issued a $14.00 price target on shares of ProPhase Labs in a report on Monday, August 14th. Get Our Latest Analysis on […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 310,300 shares, a decrease of 13.8% from the August 31st total of 360,100 shares. Based on an average daily volume of 43,600 shares, […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.25 and traded as low as $4.35. ProPhase Labs shares last traded at $4.54, with a volume of 70,859 shares trading hands. Wall Street Analysts Forecast […]

ProPhase Labs (NASDAQ:PRPH – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday. Several other equities research analysts have also commented on the stock. TheStreet lowered shares of ProPhase Labs from a “b-” rating to a “c” rating in a research […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Free Report) – HC Wainwright dropped their Q3 2023 EPS estimates for ProPhase Labs in a report released on Monday, August 14th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.19) for the quarter, down from their prior forecast of ($0.17). HC […]

ProPhase Labs (NASDAQ:PRPH – Get Rating) had its price objective decreased by HC Wainwright from $15.00 to $14.00 in a report released on Friday, The Fly reports. A number of other research firms also recently weighed in on PRPH. TheStreet raised shares of ProPhase Labs from a c rating to a b- rating in a […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 382,800 shares, a growth of 23.5% from the March 31st total of 309,900 shares. Based on an average daily volume of 45,200 shares, the days-to-cover ratio is […]